Mr. Lafleur brings more than 25 year of experience in pharmaceutical and biotech industries as well as medical and clinical to Dracen. Prior to joining Dracen, Mr. Lafleur worked at several leading biopharmaceutical companies including Ipsen, Helsinn, Celgene, Pfizer, Genentech, Sanofi and Schering-Plough. He successfully launched eight products in the US and Europe in the areas of oncology, hepatology and rheumatology. Prior to his time in industry, Mr. Lafleur spent several years at New York University Cancer Center in academic research and administration roles. He holds a Master’s in Public Health from Columbia University Mailman School of Public Health in New York city and a BS in Immunology and Microbiology from McGill University in Montreal, Canada.